Neurovascular or Interventional Neurology Devices

Neurovascular or Interventional Neurology Devices Market Outlook

The global neurovascular or interventional neurology devices market was valued at approximately USD 3.5 billion in 2023 and is projected to reach around USD 5.2 billion by 2035, growing at a CAGR of about 4.8% during the forecast period. This growth is primarily driven by the increasing prevalence of neurovascular diseases, such as ischemic stroke and brain aneurysms, alongside advancements in medical technology that have enhanced the efficacy and safety of neurovascular procedures. Moreover, the rising geriatric population across the globe, which is more susceptible to neurological disorders, and the growing awareness regarding the benefits of early diagnosis and intervention in neurovascular conditions are expected to further propel the market. The expansion of healthcare infrastructure, especially in emerging economies, coupled with favorable reimbursement policies, is also playing a pivotal role in the market's growth trajectory.

Growth Factor of the Market

One of the key growth factors for the neurovascular devices market is the increasing incidence of neurovascular disorders, which necessitates advanced treatment solutions. As the population ages, the prevalence of conditions such as ischemic stroke, brain aneurysms, and arteriovenous malformations is surging, prompting healthcare providers to seek innovative treatments that improve patient outcomes. Additionally, advancements in minimally invasive procedures are driving the adoption of interventional neurology devices, as these techniques typically result in shorter recovery times and lower risks compared to traditional open surgeries. The ongoing research and development in neurovascular technologies, including the development of new materials and techniques, are also contributing to market growth. Furthermore, the emergence of telemedicine and remote monitoring has made it easier for patients to receive timely diagnosis and intervention, thus facilitating the utilization of neurovascular devices. Increased investment in healthcare infrastructure, particularly in developing regions, is likely to open new avenues for growth in the market.

Key Highlights of the Market

• The global neurovascular devices market is projected to grow at a CAGR of 4.8% from 2025 to 2035.
• Ischemic stroke and brain aneurysms represent the largest segments in terms of application.
• North America dominates the market, accounting for a significant share of the total revenue.
• Technological advancements, particularly in stenting and embolization techniques, are enhancing treatment efficacy.
• Collaboration between medical device manufacturers and healthcare providers is increasing to improve patient access to innovative therapies.

By Product Type

Cerebral Balloon Angioplasty & Stenting Systems:

Cerebral balloon angioplasty and stenting systems are crucial devices used primarily for the treatment of carotid artery stenosis and other neurovascular disorders. These systems involve the use of a balloon catheter that is inflated to open narrowed blood vessels, followed by the placement of a stent to keep the vessel open. The growing preference for minimally invasive procedures is driving the demand for these systems, as they are associated with lower complication rates and shorter recovery times compared to traditional surgical methods. Furthermore, advancements in balloon and stent design, such as drug-eluting stents, have significantly improved patient outcomes and are likely to enhance the adoption of these devices in clinical practices.

Embolic Protection Systems:

Embolic protection systems are employed during interventional procedures to prevent emboli from entering the cerebral circulation, which can lead to severe complications such as stroke. These systems have gained traction as they enhance the safety of procedures like carotid artery stenting by filtering out debris and preventing it from reaching vital areas of the brain. The increasing incidence of cardiovascular diseases and the growing focus on patient safety during neurovascular interventions are contributing to the rising demand for embolic protection systems. The continuous evolution of these systems to enhance their efficacy while minimizing procedural risks is expected to bolster their market presence in the coming years.

Neurothrombectomy Devices:

Neurothrombectomy devices are specialized tools designed to remove blood clots from the cerebral blood vessels, particularly in patients suffering from acute ischemic stroke. The effectiveness of these devices in restoring blood flow has made them indispensable in emergency medical settings, directly impacting patient survival rates and recovery outcomes. The rise in awareness about the benefits of timely intervention in stroke cases is further fueling the demand for neurothrombectomy devices. As technologies advance, these devices are becoming more efficient and easier to use, leading to increased acceptance among healthcare providers and improved access for patients requiring urgent care.

Carotid Artery Stents:

Carotid artery stents are used to treat stenosis in the carotid arteries, thereby reducing the risk of stroke. The demand for these stents has risen in tandem with the increasing prevalence of carotid artery disease, driven by factors such as hypertension and diabetes. The introduction of innovative stent designs and materials, including bioresorbable stents, is enhancing their efficacy and biocompatibility, making them a preferred choice for both patients and clinicians. Moreover, ongoing clinical trials and studies aimed at demonstrating the long-term benefits of carotid artery stenting are expected to solidify their place in the neurovascular device market.

Intracranial Stents:

Intracranial stents are employed to treat various conditions affecting the intracranial arteries, including aneurysms and arterial stenosis. The demand for these stents is on the rise due to their effectiveness in providing support to weakened vessel walls and improving blood flow. The increasing understanding of cerebral vascular anatomy and the development of patient-specific stenting solutions are key trends contributing to the growth of this segment. Additionally, as physicians gain more experience with intracranial stenting techniques, the procedural adoption is expected to increase, further driving market growth.

By Application

Ischemic Stroke:

Ischemic stroke occurs when blood flow to a part of the brain is blocked, leading to serious health consequences. The rising prevalence of ischemic stroke due to lifestyle changes, aging population, and increased incidence of risk factors such as hypertension and diabetes is driving the demand for neurovascular devices aimed at treating this condition. The development of advanced interventional techniques, along with better imaging technologies, has enabled early diagnosis and timely intervention, which are critical in improving patient outcomes. Furthermore, the increasing awareness about the importance of rapid response in stroke management is likely to bolster the market for devices tailored for ischemic stroke treatment.

Brain Aneurysms:

Brain aneurysms are balloon-like bulges in the blood vessels of the brain that can rupture, leading to life-threatening complications. The increasing incidence of brain aneurysms, coupled with advancements in neurovascular technologies, is driving the demand for devices specifically designed for their treatment. Endovascular techniques, which utilize devices such as coils and stents, have become the preferred method for managing brain aneurysms due to their minimally invasive nature and effective outcomes. The ongoing research into innovative materials and techniques for treating aneurysms is expected to further enhance the growth of this segment within the neurovascular devices market.

Arteriovenous Malformations:

Arteriovenous malformations (AVMs) are abnormal connections between arteries and veins in the brain, which can lead to serious complications such as hemorrhagic stroke. The treatment of AVMs often requires a combination of interventional techniques, including embolization and surgical resection. As awareness of AVMs increases and diagnostic capabilities improve, the demand for neurovascular devices targeting this condition is on the rise. The development of advanced embolic materials and techniques specifically designed for AVM management is likely to enhance treatment success rates and contribute to the overall growth of the neurovascular devices market.

Others:

This segment includes various other applications of neurovascular devices, including the treatment of conditions such as venous sinus thrombosis and cerebral cavernous malformations. The growth in this category is largely driven by the continued evolution of neurovascular treatments and the increasing recognition of the importance of individualized patient care. As new techniques and devices are developed to address these less common yet significant conditions, the market for neurovascular devices will expand, ensuring that patients receive comprehensive care across a range of neurovascular disorders.

By Distribution Channel

Hospitals:

Hospitals represent the largest distribution channel for neurovascular devices, primarily due to their comprehensive facilities and critical care capabilities. As the primary healthcare setting for acute and chronic neurovascular conditions, hospitals are equipped with advanced imaging and intervention technologies, thereby facilitating the timely application of neurovascular treatments. The growing incidence of neurological disorders necessitates a robust hospital infrastructure to support the increasing demand for these devices. Moreover, hospitals typically collaborate with leading medical device manufacturers to ensure access to the latest technologies, further solidifying their role as key players in the neurovascular devices market.

Specialty Clinics:

Specialty clinics are emerging as significant distribution channels in the neurovascular devices market, primarily due to their focus on specific neurological conditions and treatments. These clinics often provide tailored care, appealing to patients seeking specialized services. The increasing preference for outpatient care, coupled with the growing trend of patient-centered healthcare, is driving the demand for neurovascular devices within specialty clinics. As these clinics adopt more advanced interventional techniques and technologies, they will play a crucial role in meeting the rising demand for neurovascular treatments.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) offer minimally invasive surgical procedures on an outpatient basis, which is advantageous for both patients and healthcare systems. The rise of ASCs is driven by their ability to provide cost-effective procedures while maintaining high-quality care. As neurovascular procedures increasingly shift towards outpatient settings, the demand for neurovascular devices in ASCs is expected to grow. The convenience and efficiency associated with ASCs, along with the focus on patient satisfaction and quicker recovery times, are likely to enhance their significance in the neurovascular devices market.

Others:

This category encompasses various other distribution channels, including home healthcare and online platforms. The rise of telehealth services and remote monitoring technologies has made it possible for patients to access neurovascular care from the comfort of their homes. The growing emphasis on patient-centered care and the demand for convenience are driving the need for innovative distribution methods. As more patients seek alternatives to traditional healthcare settings, the potential of these emerging channels to contribute to the neurovascular devices market is likely to expand in the coming years.

By Technology

Balloon Angioplasty:

Balloon angioplasty is a minimally invasive procedure that involves the use of a balloon catheter to widen narrowed blood vessels in the brain. This technique is crucial for treating conditions like carotid artery stenosis and is preferred due to its effectiveness in restoring blood flow without the need for major surgery. The technological advancements in balloon design, including improved deflation and inflation mechanisms, have enhanced the safety and efficacy of this procedure. With the rising prevalence of ischemic conditions and increased awareness about the benefits of angioplasty, this segment is expected to experience significant growth in the neurovascular devices market.

Stenting:

Stenting involves placing a small mesh tube into a narrowed artery to keep it open and ensure proper blood flow. This technology has become increasingly popular in neurovascular interventions due to its minimal invasiveness and effectiveness in treating conditions such as carotid artery disease and brain aneurysms. The development of new stent designs, including drug-eluting stents, provides added benefits such as reduced restenosis rates. The growing adoption of stenting techniques in clinical practice is likely to drive the demand for stenting technologies, thereby enhancing their position in the neurovascular devices market.

Coil Embolization:

Coil embolization is a technique used to treat brain aneurysms through the insertion of tiny coils into the aneurysm sac, promoting clot formation and preventing rupture. This method has gained acceptance due to its minimally invasive nature, which significantly reduces recovery time compared to traditional surgical approaches. The increasing prevalence of brain aneurysms and the growing understanding of the benefits of early intervention are propelling the demand for coil embolization technologies. Additionally, advancements in coil design and delivery systems are likely to enhance the efficacy of this procedure, further driving its market growth.

Carotid Endarterectomy:

Carotid endarterectomy is a surgical procedure aimed at reducing the risk of stroke by correcting stenosis in the common carotid artery. Although it is more invasive than other techniques, the procedure remains essential for patients with severe carotid artery disease. The increasing recognition of the importance of timely intervention in stroke prevention is expected to sustain the demand for carotid endarterectomy techniques. Continuous improvements in surgical methodologies and patient management strategies are likely to enhance outcomes for patients undergoing this procedure, reinforcing its relevance in the neurovascular devices market.

Neurothrombectomy:

Neurothrombectomy involves the removal of blood clots from cerebral vessels, particularly in patients suffering from acute ischemic stroke. The growing recognition of the critical importance of timely intervention in stroke management is driving the demand for neurothrombectomy technologies. Recent advancements in mechanical thrombectomy devices have improved their efficacy, making them a standard treatment option for eligible patients. As awareness about stroke symptoms and the significance of rapid treatment grows, the neurothrombectomy segment is expected to expand significantly, bolstered by ongoing research and technological innovations.

By Region

The neurovascular devices market is geographically segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds a prominent position in the market, accounting for approximately 45% of the total share, driven by the advanced healthcare infrastructure, high prevalence of neurological disorders, and the presence of leading medical device manufacturers. The market in this region is expected to grow at a CAGR of 5.2% during the forecast period, supported by increasing investments in healthcare and a robust regulatory framework that fosters innovation.

Europe follows North America, with a market share of around 30%. The growing demand for minimally invasive surgical procedures and the increasing focus on improving patient outcomes are significant factors driving the neurovascular devices market in this region. Meanwhile, the Asia Pacific region is anticipated to witness the highest growth rate at a CAGR of 6.1%, fueled by the rising prevalence of neurovascular conditions, improving healthcare infrastructure, and increasing government initiatives to enhance healthcare access. The Latin America and Middle East & Africa regions are also expected to contribute to market growth, albeit at a slower pace due to varying levels of healthcare development and market maturity.

Opportunities

The neurovascular devices market presents several opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly evolving. As countries in regions like Asia Pacific and Latin America continue to invest in their healthcare systems, the demand for advanced medical technologies, including neurovascular devices, is set to increase. Companies that strategically position themselves to cater to this demand can benefit significantly from market expansion. Additionally, public-private partnerships aimed at enhancing healthcare services and access in underserved areas can further create pathways for growth. The increasing collaboration between medical device manufacturers and healthcare providers to develop innovative solutions tailored to local needs is also expected to create new opportunities in the market.

Furthermore, the advancement of telemedicine and remote patient monitoring is poised to revolutionize the neurovascular devices market. These technologies allow for early diagnosis and intervention, which is critical in managing neurovascular conditions effectively. By integrating digital health solutions with traditional neurovascular devices, companies can enhance patient engagement and adherence to treatment protocols. The growing emphasis on personalized medicine and tailored treatments is also providing avenues for innovation in device design and functionality. As healthcare continues to evolve, the neurovascular devices market is likely to see an influx of innovative products aimed at improving patient outcomes and enhancing treatment efficacy.

Threats

Despite the promising growth prospects, the neurovascular devices market faces several threats that could hinder its expansion. One of the primary challenges is the stringent regulatory environment governing medical devices, which can prolong the time-to-market for new products. Manufacturers must navigate complex approval processes to ensure compliance with safety and efficacy standards set by regulatory bodies, which can be resource-intensive. Additionally, the competition within the market is intensifying as new players enter the space, leading to price wars and potential erosion of profit margins. Companies must invest heavily in research and development to maintain a competitive edge while also addressing the growing demand for cost-effective solutions.

Another significant threat is the increasing preference for alternative treatment options, including pharmacological therapies that may reduce the reliance on invasive devices. As advancements in drug therapies continue, there is a risk that certain neurovascular conditions could be managed without the need for surgical intervention, impacting device sales. Furthermore, the ongoing global economic uncertainties and fluctuations in healthcare spending could pose challenges for market growth, particularly in regions with less stable economies. To mitigate these risks, companies must adopt agile business strategies and continuously adapt to changing market dynamics.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Terumo Corporation
• Johnson & Johnson (DePuy Synthes)
• Cerenovus (a subsidiary of Johnson & Johnson)
• Stryker Corporation
• Penumbra, Inc.
• MicroVention, Inc.
• Asahi Intecc Co., Ltd.
• Nico Corporation
• InspireMD, Inc.
• B. Braun Melsungen AG
• Endologix, Inc.
• Cook Medical

The competitive landscape of the neurovascular devices market is characterized by the presence of several key players that are consistently innovating to maintain their market positions. Medtronic, a leading global medical technology company, offers a wide range of neurovascular devices and has a strong emphasis on research and development to bring new products to market. Their advanced technologies, including neurothrombectomy and embolization devices, have set industry standards and positioned them as a leader in the neurovascular space. Boston Scientific is another major player, recognized for its comprehensive portfolio of neuromodulation devices and innovative solutions for treating neurovascular conditions. Their continuous focus on enhancing patient outcomes through technological advancements has fostered brand loyalty among healthcare providers.

Abbott Laboratories has also established a significant presence in the neurovascular devices market, with a strong emphasis on innovation and quality. Their stenting solutions and embolization systems are widely utilized in clinical practice due to their efficacy and safety profiles. The company’s commitment to enhancing patient care through advanced medical technologies is reflected in its ongoing investment in research and development. Similarly, Stryker Corporation has made substantial inroads into the neurovascular segment, with its cutting-edge technologies for neurothrombectomy and innovative stenting solutions, which have garnered positive feedback from the medical community.

Asahi Intecc Co., Ltd. and Penumbra, Inc. are notable competitors that are gaining recognition for their specialized products designed to improve the efficiency of neurovascular procedures. Asahi Intecc’s focus on high-quality guidewires and catheter systems has positioned them favorably in the market. Meanwhile, Penumbra has emerged as a key player in the thrombectomy market, thanks to its innovative devices that are specifically designed for the treatment of ischemic stroke. The competitive landscape is continuously evolving, with new entrants bringing novel technologies and approaches, thereby enhancing the overall market dynamics.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Penumbra, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Endologix, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 InspireMD, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Nico Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 MicroVention, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 B. Braun Melsungen AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Asahi Intecc Co., Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Johnson & Johnson (DePuy Synthes)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Cerenovus (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Neurovascular or Interventional Neurology Devices Market, By Technology
    • 6.1.1 Balloon Angioplasty
    • 6.1.2 Stenting
    • 6.1.3 Coil Embolization
    • 6.1.4 Carotid Endarterectomy
    • 6.1.5 Neurothrombectomy
  • 6.2 Neurovascular or Interventional Neurology Devices Market, By Application
    • 6.2.1 Ischemic Stroke
    • 6.2.2 Brain Aneurysms
    • 6.2.3 Arteriovenous Malformations
    • 6.2.4 Others
  • 6.3 Neurovascular or Interventional Neurology Devices Market, By Product Type
    • 6.3.1 Cerebral Balloon Angioplasty & Stenting Systems
    • 6.3.2 Embolic Protection Systems
    • 6.3.3 Neurothrombectomy Devices
    • 6.3.4 Carotid Artery Stents
    • 6.3.5 Intracranial Stents
  • 6.4 Neurovascular or Interventional Neurology Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Neurovascular or Interventional Neurology Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Neurovascular or Interventional Neurology Devices market is categorized based on

By Product Type

• Cerebral Balloon Angioplasty & Stenting Systems
• Embolic Protection Systems
• Neurothrombectomy Devices
• Carotid Artery Stents
• Intracranial Stents

By Application

• Ischemic Stroke
• Brain Aneurysms
• Arteriovenous Malformations
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Technology

• Balloon Angioplasty
• Stenting
• Coil Embolization
• Carotid Endarterectomy
• Neurothrombectomy

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Terumo Corporation
• Johnson & Johnson (DePuy Synthes)
• Cerenovus (a subsidiary of Johnson & Johnson)
• Stryker Corporation
• Penumbra, Inc.
• MicroVention, Inc.
• Asahi Intecc Co., Ltd.
• Nico Corporation
• InspireMD, Inc.
• B. Braun Melsungen AG
• Endologix, Inc.
• Cook Medical